Centru De Evaluare Si Tratament A Toxicodependentelor Pentru Tineri Sf. Stelian

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Depression5 trials
• Bipolar disorder3 trials
• Schizophrenia3 trials
• Alzheimer disease2 trials

Phase

• Phase 39 trials
• Phase 22 trials
• Early phase 11 trial

Status

• Recruiting6 trials
• Completed4 trials
• Suspended2 trials

Lead sponsor

• Neurocrine Biosciences3 trials
• Intra-Cellular Therapies Inc.2 trials
• Bristol-Myers Squibb1 trial
• Intra-Cellular Therapies, Inc.1 trial
• Janssen Cilag International1 trial
• and 4 more

Running trials

• Recruiting

  A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  NCT06929273· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease

  2024-513035-25-00· Phase 2· Intra-Cellular Therapies Inc.· Source

• Recruiting

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· Phase 3· Neurocrine Biosciences· Source

• Recruiting

  NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06911112· Phase 3· Neurocrine Biosciences· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

  NCT06651567· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia

  NCT05325645· Phase 3· Otsuka Pharmaceutical Co., Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Depression2 recruiting
• Bipolar disorder1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania

  2024-513037-20-00· Phase 3· Intra-Cellular Therapies Inc.· Source

• Completed

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

  2024-511057-22-00· Phase 3· Janssen Cilag International· Source

• Completed

  Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia

  2022-502233-25-00· Phase 3· Neurocrine Biosciences Inc.· Source

• Completed

  Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

  NCT05110157· Phase 3· Neurocrine Biosciences· Source